Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
The Role of Iron and Siderophores in Infection, and the Development of Siderophore Antibiotics
by
Page, Malcom G. P.
in
Bacterial Infections - drug therapy
/ beta-Lactams - pharmacology
/ Cefiderocol
/ Cephalosporins - chemistry
/ Cephalosporins - pharmacology
/ Drug Design
/ Drug Development
/ Drug Resistance, Bacterial
/ Gram-Negative Bacteria - drug effects
/ Humans
/ Iron - metabolism
/ Models, Molecular
/ Siderophores - chemistry
/ Siderophores - pharmacology
/ Supplement
/ SUPPLEMENT ARTICLES
2019
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
The Role of Iron and Siderophores in Infection, and the Development of Siderophore Antibiotics
by
Page, Malcom G. P.
in
Bacterial Infections - drug therapy
/ beta-Lactams - pharmacology
/ Cefiderocol
/ Cephalosporins - chemistry
/ Cephalosporins - pharmacology
/ Drug Design
/ Drug Development
/ Drug Resistance, Bacterial
/ Gram-Negative Bacteria - drug effects
/ Humans
/ Iron - metabolism
/ Models, Molecular
/ Siderophores - chemistry
/ Siderophores - pharmacology
/ Supplement
/ SUPPLEMENT ARTICLES
2019
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
The Role of Iron and Siderophores in Infection, and the Development of Siderophore Antibiotics
by
Page, Malcom G. P.
in
Bacterial Infections - drug therapy
/ beta-Lactams - pharmacology
/ Cefiderocol
/ Cephalosporins - chemistry
/ Cephalosporins - pharmacology
/ Drug Design
/ Drug Development
/ Drug Resistance, Bacterial
/ Gram-Negative Bacteria - drug effects
/ Humans
/ Iron - metabolism
/ Models, Molecular
/ Siderophores - chemistry
/ Siderophores - pharmacology
/ Supplement
/ SUPPLEMENT ARTICLES
2019
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
The Role of Iron and Siderophores in Infection, and the Development of Siderophore Antibiotics
Journal Article
The Role of Iron and Siderophores in Infection, and the Development of Siderophore Antibiotics
2019
Request Book From Autostore
and Choose the Collection Method
Overview
Iron is an essential nutrient for bacterial growth, replication, and metabolism. Humans store iron bound to various proteins such as hemoglobin, haptoglobin, transferrin, ferritin, and lactoferrin, limiting the availability of free iron for pathogenic bacteria. However, bacteria have developed various mechanisms to sequester or scavenge iron from the host environment. Iron can be taken up by means of active transport systems that consist of bacterial small molecule siderophores, outer membrane siderophore receptors, the TonB-ExbBD energy-transducing proteins coupling the outer and the inner membranes, and inner membrane transporters. Some bacteria also express outer membrane receptors for iron-binding proteins of the host and extract iron directly from these for uptake. Ultimately, iron is acquired and transported into the bacterial cytoplasm. The siderophores are small molecules produced and released by nearly all bacterial species and are classified according to the chemical nature of their iron-chelating group (ie, catechol, hydroxamate, α-hydroxyl-carboxylate, or mixed types). Siderophore-conjugated antibiotics that exploit such iron-transport systems are under development for the treatment of infections caused by gram-negative bacteria. Despite demonstrating high in vitro potency against pathogenic multidrug-resistant bacteria, further development of several candidates had stopped due to apparent adaptive resistance during exposure, lack of consistent in vivo efficacy, or emergence of side effects in the host. However, cefiderocol, with an optimized structure, has advanced and has been investigated in phase 1 to 3 clinical trials. This article discusses the mechanisms implicated in iron uptake and the challenges associated with the design and utilization of siderophore-mimicking antibiotics.
Publisher
Oxford University Press
This website uses cookies to ensure you get the best experience on our website.